China SXT Pharmaceuticals, Inc. (SXTC)
- Previous Close
1.0400 - Open
1.0100 - Bid 0.7992 x 200
- Ask 1.3000 x 200
- Day's Range
1.0100 - 1.1350 - 52 Week Range
0.9400 - 9.3750 - Volume
240,114 - Avg. Volume
1,007,036 - Market Cap (intraday)
624,914 - Beta (5Y Monthly) 1.10
- PE Ratio (TTM)
-- - EPS (TTM)
-26.9600 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company had an end-customer base of pharmaceutical companies, chain pharmacies, and hospitals in 10 provinces and municipalities in China. China SXT Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Taizhou, China.
www.sxtchina.com78
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: SXTC
Performance Overview: SXTC
Trailing total returns as of 5/14/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SXTC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SXTC
Valuation Measures
Market Cap
588.15k
Enterprise Value
-7.73M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.28
Price/Book (mrq)
0.12
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-45.75%
Return on Equity (ttm)
-141.60%
Revenue (ttm)
1.7M
Net Income Avi to Common (ttm)
-14.14M
Diluted EPS (ttm)
-26.9600
Balance Sheet and Cash Flow
Total Cash (mrq)
11.47M
Total Debt/Equity (mrq)
70.37%
Levered Free Cash Flow (ttm)
-400.4k
Research Analysis: SXTC
Company Insights: SXTC
SXTC does not have Company Insights